nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—Respiratory insufficiency—Tretinoin—peripheral nervous system neoplasm	0.0459	0.0591	CcSEcCtD
Rocuronium—Respiratory insufficiency—Isotretinoin—peripheral nervous system neoplasm	0.0459	0.0591	CcSEcCtD
Rocuronium—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.0416	0.241	CbGeAlD
Rocuronium—Respiratory insufficiency—Alitretinoin—peripheral nervous system neoplasm	0.0348	0.0448	CcSEcCtD
Rocuronium—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.0317	0.184	CbGeAlD
Rocuronium—CHRNA1—tongue—peripheral nervous system neoplasm	0.0267	0.155	CbGeAlD
Rocuronium—Pipecuronium—BCHE—peripheral nervous system neoplasm	0.0223	0.431	CrCbGaD
Rocuronium—Pancuronium—BCHE—peripheral nervous system neoplasm	0.0202	0.39	CrCbGaD
Rocuronium—HTR3A—nerve—peripheral nervous system neoplasm	0.0162	0.0942	CbGeAlD
Rocuronium—HTR3A—ganglion—peripheral nervous system neoplasm	0.016	0.0931	CbGeAlD
Rocuronium—Cardiovascular disorder—Tretinoin—peripheral nervous system neoplasm	0.0158	0.0203	CcSEcCtD
Rocuronium—Cardiovascular disorder—Isotretinoin—peripheral nervous system neoplasm	0.0158	0.0203	CcSEcCtD
Rocuronium—Paralysis—Vincristine—peripheral nervous system neoplasm	0.0146	0.0188	CcSEcCtD
Rocuronium—Respiratory failure—Topotecan—peripheral nervous system neoplasm	0.0142	0.0183	CcSEcCtD
Rocuronium—Respiratory failure—Tretinoin—peripheral nervous system neoplasm	0.0141	0.0182	CcSEcCtD
Rocuronium—Respiratory failure—Isotretinoin—peripheral nervous system neoplasm	0.0141	0.0182	CcSEcCtD
Rocuronium—Wheezing—Tretinoin—peripheral nervous system neoplasm	0.0135	0.0173	CcSEcCtD
Rocuronium—Wheezing—Isotretinoin—peripheral nervous system neoplasm	0.0135	0.0173	CcSEcCtD
Rocuronium—SLC22A1—ganglion—peripheral nervous system neoplasm	0.0131	0.0763	CbGeAlD
Rocuronium—Cardiovascular disorder—Alitretinoin—peripheral nervous system neoplasm	0.0119	0.0154	CcSEcCtD
Rocuronium—Respiratory failure—Alitretinoin—peripheral nervous system neoplasm	0.0107	0.0138	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.0105	0.0135	CcSEcCtD
Rocuronium—Respiratory failure—Vincristine—peripheral nervous system neoplasm	0.0103	0.0133	CcSEcCtD
Rocuronium—Wheezing—Alitretinoin—peripheral nervous system neoplasm	0.0102	0.0131	CcSEcCtD
Rocuronium—Apnoea—Etoposide—peripheral nervous system neoplasm	0.00967	0.0125	CcSEcCtD
Rocuronium—Cardiovascular disorder—Etoposide—peripheral nervous system neoplasm	0.00933	0.012	CcSEcCtD
Rocuronium—Vecuronium—ABCB1—peripheral nervous system neoplasm	0.0093	0.18	CrCbGaD
Rocuronium—Hiccups—Cisplatin—peripheral nervous system neoplasm	0.00894	0.0115	CcSEcCtD
Rocuronium—Asthma—Isotretinoin—peripheral nervous system neoplasm	0.00869	0.0112	CcSEcCtD
Rocuronium—Asthma—Tretinoin—peripheral nervous system neoplasm	0.00869	0.0112	CcSEcCtD
Rocuronium—Wheezing—Cisplatin—peripheral nervous system neoplasm	0.00869	0.0112	CcSEcCtD
Rocuronium—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.00855	0.011	CcSEcCtD
Rocuronium—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.00855	0.011	CcSEcCtD
Rocuronium—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.00844	0.0109	CcSEcCtD
Rocuronium—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.00787	0.0457	CbGeAlD
Rocuronium—HTR3A—brainstem—peripheral nervous system neoplasm	0.00697	0.0405	CbGeAlD
Rocuronium—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00671	0.00865	CcSEcCtD
Rocuronium—Paralysis—Epirubicin—peripheral nervous system neoplasm	0.00661	0.00852	CcSEcCtD
Rocuronium—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00659	0.00849	CcSEcCtD
Rocuronium—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.00648	0.00835	CcSEcCtD
Rocuronium—Muscular weakness—Vincristine—peripheral nervous system neoplasm	0.00648	0.00835	CcSEcCtD
Rocuronium—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.00621	0.00801	CcSEcCtD
Rocuronium—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.00621	0.00801	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.00615	0.00792	CcSEcCtD
Rocuronium—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00613	0.0079	CcSEcCtD
Rocuronium—Paralysis—Doxorubicin—peripheral nervous system neoplasm	0.00612	0.00788	CcSEcCtD
Rocuronium—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00523	0.00674	CcSEcCtD
Rocuronium—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00523	0.00674	CcSEcCtD
Rocuronium—Cardiovascular disorder—Epirubicin—peripheral nervous system neoplasm	0.00523	0.00674	CcSEcCtD
Rocuronium—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00506	0.00652	CcSEcCtD
Rocuronium—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00498	0.00642	CcSEcCtD
Rocuronium—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00494	0.00637	CcSEcCtD
Rocuronium—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00494	0.00637	CcSEcCtD
Rocuronium—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00488	0.00629	CcSEcCtD
Rocuronium—Shock—Tretinoin—peripheral nervous system neoplasm	0.00486	0.00627	CcSEcCtD
Rocuronium—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00486	0.00627	CcSEcCtD
Rocuronium—Cardiovascular disorder—Doxorubicin—peripheral nervous system neoplasm	0.00484	0.00623	CcSEcCtD
Rocuronium—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00482	0.00622	CcSEcCtD
Rocuronium—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00482	0.00622	CcSEcCtD
Rocuronium—CHRNA2—cerebellum—peripheral nervous system neoplasm	0.00481	0.0279	CbGeAlD
Rocuronium—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00476	0.00614	CcSEcCtD
Rocuronium—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00471	0.00607	CcSEcCtD
Rocuronium—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00462	0.00595	CcSEcCtD
Rocuronium—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00462	0.00595	CcSEcCtD
Rocuronium—Hiccups—Epirubicin—peripheral nervous system neoplasm	0.00459	0.00592	CcSEcCtD
Rocuronium—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00456	0.00587	CcSEcCtD
Rocuronium—CHRNB1—cerebellum—peripheral nervous system neoplasm	0.00447	0.026	CbGeAlD
Rocuronium—Hiccups—Doxorubicin—peripheral nervous system neoplasm	0.00425	0.00548	CcSEcCtD
Rocuronium—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00401	0.00517	CcSEcCtD
Rocuronium—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00396	0.00511	CcSEcCtD
Rocuronium—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00382	0.00492	CcSEcCtD
Rocuronium—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00375	0.00483	CcSEcCtD
Rocuronium—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00368	0.00475	CcSEcCtD
Rocuronium—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00367	0.00473	CcSEcCtD
Rocuronium—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00366	0.00471	CcSEcCtD
Rocuronium—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00364	0.00469	CcSEcCtD
Rocuronium—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00364	0.00469	CcSEcCtD
Rocuronium—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00361	0.00465	CcSEcCtD
Rocuronium—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00359	0.00463	CcSEcCtD
Rocuronium—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00352	0.00454	CcSEcCtD
Rocuronium—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.0035	0.00451	CcSEcCtD
Rocuronium—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0035	0.00451	CcSEcCtD
Rocuronium—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0035	0.00451	CcSEcCtD
Rocuronium—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00345	0.00445	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00345	0.00444	CcSEcCtD
Rocuronium—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00337	0.00435	CcSEcCtD
Rocuronium—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00319	0.00411	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00319	0.00411	CcSEcCtD
Rocuronium—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00317	0.00408	CcSEcCtD
Rocuronium—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00314	0.00405	CcSEcCtD
Rocuronium—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00314	0.00405	CcSEcCtD
Rocuronium—Rash—Topotecan—peripheral nervous system neoplasm	0.00314	0.00405	CcSEcCtD
Rocuronium—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00314	0.00404	CcSEcCtD
Rocuronium—Rash—Tretinoin—peripheral nervous system neoplasm	0.00312	0.00402	CcSEcCtD
Rocuronium—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00312	0.00402	CcSEcCtD
Rocuronium—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00311	0.00401	CcSEcCtD
Rocuronium—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00311	0.00401	CcSEcCtD
Rocuronium—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00311	0.00401	CcSEcCtD
Rocuronium—Vomiting—Melphalan—peripheral nervous system neoplasm	0.0031	0.004	CcSEcCtD
Rocuronium—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00309	0.00399	CcSEcCtD
Rocuronium—Rash—Melphalan—peripheral nervous system neoplasm	0.00308	0.00396	CcSEcCtD
Rocuronium—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00307	0.00396	CcSEcCtD
Rocuronium—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00298	0.00384	CcSEcCtD
Rocuronium—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00298	0.00384	CcSEcCtD
Rocuronium—Nausea—Topotecan—peripheral nervous system neoplasm	0.00296	0.00381	CcSEcCtD
Rocuronium—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00294	0.00379	CcSEcCtD
Rocuronium—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00294	0.00378	CcSEcCtD
Rocuronium—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00294	0.00378	CcSEcCtD
Rocuronium—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00292	0.00377	CcSEcCtD
Rocuronium—Nausea—Melphalan—peripheral nervous system neoplasm	0.0029	0.00373	CcSEcCtD
Rocuronium—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00288	0.00371	CcSEcCtD
Rocuronium—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00285	0.00368	CcSEcCtD
Rocuronium—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00276	0.00356	CcSEcCtD
Rocuronium—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00273	0.00352	CcSEcCtD
Rocuronium—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00272	0.00351	CcSEcCtD
Rocuronium—SLCO1A2—cerebellum—peripheral nervous system neoplasm	0.00271	0.0157	CbGeAlD
Rocuronium—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00267	0.00344	CcSEcCtD
Rocuronium—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00266	0.00343	CcSEcCtD
Rocuronium—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00265	0.00341	CcSEcCtD
Rocuronium—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00257	0.00331	CcSEcCtD
Rocuronium—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00255	0.00328	CcSEcCtD
Rocuronium—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0024	0.00309	CcSEcCtD
Rocuronium—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00238	0.00307	CcSEcCtD
Rocuronium—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.00304	CcSEcCtD
Rocuronium—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.00304	CcSEcCtD
Rocuronium—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00235	0.00303	CcSEcCtD
Rocuronium—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00229	0.00296	CcSEcCtD
Rocuronium—Rash—Vincristine—peripheral nervous system neoplasm	0.00228	0.00293	CcSEcCtD
Rocuronium—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00227	0.00293	CcSEcCtD
Rocuronium—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00222	0.00287	CcSEcCtD
Rocuronium—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00215	0.00278	CcSEcCtD
Rocuronium—Nausea—Vincristine—peripheral nervous system neoplasm	0.00214	0.00276	CcSEcCtD
Rocuronium—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00207	0.00267	CcSEcCtD
Rocuronium—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00266	CcSEcCtD
Rocuronium—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00203	0.00261	CcSEcCtD
Rocuronium—Rash—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00259	CcSEcCtD
Rocuronium—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00259	CcSEcCtD
Rocuronium—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00246	CcSEcCtD
Rocuronium—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0019	0.00244	CcSEcCtD
Rocuronium—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00186	0.0024	CcSEcCtD
Rocuronium—Rash—Etoposide—peripheral nervous system neoplasm	0.00184	0.00238	CcSEcCtD
Rocuronium—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00184	0.00237	CcSEcCtD
Rocuronium—Nausea—Etoposide—peripheral nervous system neoplasm	0.00174	0.00224	CcSEcCtD
Rocuronium—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00173	0.00223	CcSEcCtD
Rocuronium—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00211	CcSEcCtD
Rocuronium—Shock—Epirubicin—peripheral nervous system neoplasm	0.00161	0.00208	CcSEcCtD
Rocuronium—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.00207	CcSEcCtD
Rocuronium—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00206	CcSEcCtD
Rocuronium—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00197	CcSEcCtD
Rocuronium—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00195	CcSEcCtD
Rocuronium—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00192	CcSEcCtD
Rocuronium—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00191	CcSEcCtD
Rocuronium—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00183	CcSEcCtD
Rocuronium—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00156	CcSEcCtD
Rocuronium—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00149	CcSEcCtD
Rocuronium—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00144	CcSEcCtD
Rocuronium—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00138	CcSEcCtD
Rocuronium—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00134	CcSEcCtD
Rocuronium—Rash—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00133	CcSEcCtD
Rocuronium—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00133	CcSEcCtD
Rocuronium—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000973	0.00125	CcSEcCtD
Rocuronium—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000964	0.00124	CcSEcCtD
Rocuronium—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000956	0.00123	CcSEcCtD
Rocuronium—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000955	0.00123	CcSEcCtD
Rocuronium—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000901	0.00116	CcSEcCtD
